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Rapid Identiﬁ cation of Scrapie-Infected Animals
       Srinand Sreevatsan, Food Animal Health Research Program
Scrapie in sheep and goats is an example of Transmissible Spongiform 
Encephalopathies (TSEs), a degenerative form of neurological disease that 
occurs in several animal species and humans. This group of diseases includes chronic 
wasting disease and bovine spongiform encephalopathy (BSE), also known as mad-cow disease. 
The human disease is known as Creutzfeld-Jacob disease (CJD). 
At present, a deﬁ nitive diagnosis of these diseases is possible only after death.  Therefore, tests 
to identify cases early, during disease development and progression, are desperately needed to 
prevent and control the transmission of TSEs. Currently, the diagnosis of TSEs is made by clinical 
presentation wherein the diagnostic error is more than 25%. 
What is needed is a test that can be performed on blood or other body ﬂ uids for the purpose of 
detecting the disease before the onset of clinical symptoms. With early detection, the possibility 
exists for developing drug treatments that may avert or control the disease.
In order to develop a diagnostic test early during progression of TSEs, we investigated the useful-
ness of two biochemicals, named 14-3-3 and S-100, which are released into the brain ﬂ uid, the 
cerebrospinal ﬂ uid (CSF), or serum. These proteins are usually present inside the brain cells but 
invariably absent in CSF and serum. 
The proteins are released from the brain cells into cerebrospinal ﬂ uid and serum when there is 
damage to the cells, such as during the progression of TSEs. Therefore, the presence of these chemi-
cals, albeit in very small quantities, is indicative of brain damage consistent with TSEs.
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O B J E C T I V E S
The objectives of this work were to design, develop, and evaluate an accurate assay to 
detect the presence of two biochemicals in cerebrospinal ﬂ uid or serum and evaluate a 
rapid test device for TSEs.
C H A L L E N G E S
At present, the diagnosis of TSEs — which include bovine spongiform encephalopathy, 
known as mad-cow disease, and the human disease known as Creutzfeld-Jacob disease — 
can only be done after death. Early detection of TSEs is the essential ﬁ rst step toward the 
development of control strategies.
A C H I E V E M E N T S
Two techniques were developed to detect proteins in the cerebrospinal ﬂ uid (CSF) and 
serum of scrapie-infected and normal sheep. A western-blot technique that detects the 
presence or absence of proteins, based on reactivity to speciﬁ c antibodies, was ﬁ rst 
developed. In order to facilitate quantitation of both S-100 and 14-3-3, an enzyme-linked 
immunosorbant assay (ELISA) was developed. The data revealed that levels of S-100 in 
serum and 14-3-3 in serum or CSF are potentially useful as surrogate markers of neuro-
logical damage early in scrapie infection.
T H E  F U T U R E  
The data from this project and data gathered from an RECGP Interdisciplinary Grant were 
used to write a successful Department of Defense proposal for $375,000. This will enable 
additional studies using large sample sizes to valide the markers for routine diagnostics of 
TSEs in ﬁ eld animals. This is a critical step forward in meeting the needs for an accurate 
diagnostic test for TSEs prior to death of the animal.
